TLX is about to have FDA approval for their imaging... probably about 3 years infront
- Forums
- ASX - By Stock
- CU6
- Ann: First patient treated in theranostic prostate cancer trial
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
1.85%
!
$3.18

Ann: First patient treated in theranostic prostate cancer trial, page-10
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$3.18 |
Change
-0.060(1.85%) |
Mkt cap ! $1.047B |
Open | High | Low | Value | Volume |
$3.18 | $3.20 | $3.18 | $538.9K | 169.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 4853 | $3.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.20 | 20892 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 3.180 |
2 | 1639 | 3.170 |
2 | 15475 | 3.160 |
5 | 21057 | 3.150 |
1 | 7637 | 3.140 |
Price($) | Vol. | No. |
---|---|---|
3.200 | 21541 | 3 |
3.220 | 19367 | 4 |
3.230 | 27637 | 2 |
3.240 | 16805 | 3 |
3.250 | 5431 | 2 |
Last trade - 10.01am 16/07/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online